Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Deirdre Moloney
SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Altered Androgen Receptor Activity Drives CHD1-Null Prostate Cancer
Cancer Discovery
Oncology
SPOP Promotes ATF2 Ubiquitination and Degradation to Suppress Prostate Cancer Progression
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
SPOP Suppresses Prostate Cancer Through Regulation of CYCLIN E1 Stability
Cell Death and Differentiation
Cell Biology
Molecular Biology
Mp68-12 Impact of Spop Mutation on Prostate Cancer Prognosis
Journal of Urology
Urology
Aneuploidy Drives Lethal Progression in Prostate Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer
Clinical Medicine Insights: Urology
Structures of Cytochrome P450 17A1 With Prostate Cancer Drugs Abiraterone and TOK-001
Nature
Multidisciplinary
Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
Expanding the Use of Abiraterone in Prostate Cancer: Is Earlier Always Better?
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology